[HTML][HTML] Signal pathways in the treatment of Alzheimer's disease with traditional Chinese medicine

MR Ding, YJ Qu, B Hu, HM An - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Aim of the review This study aimed to reveal the classical signal pathways and important
potential targets of traditional Chinese medicine (TCM) for treating Alzheimer's disease (AD) …

A review on recent approaches on molecular docking studies of novel compounds targeting acetylcholinesterase in Alzheimer disease

SC Peitzika, E Pontiki - Molecules, 2023 - mdpi.com
Alzheimer's disease (AD), a neurodegenerative brain disorder that affects millions of people
worldwide, is characterized by memory loss and cognitive decline. Low levels of …

Metals in Alzheimer's disease

M Babić Leko, L Langer Horvat, E Španić Popovački… - Biomedicines, 2023 - mdpi.com
The role of metals in the pathogenesis of Alzheimer's disease (AD) is still debated. Although
previous research has linked changes in essential metal homeostasis and exposure to …

[HTML][HTML] Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications

L Zou, M Liao, Y Zhen, S Zhu, X Chen, J Zhang… - … Pharmaceutica Sinica B, 2022 - Elsevier
Abstract UNC-51-like kinase 1 (ULK1), as a serine/threonine kinase, is an autophagic
initiator in mammals and a homologous protein of autophagy related protein (Atg) 1 in yeast …

Lysosome-targeted fluorescent probes: Design mechanism and biological applications

X Duan, Q Tong, C Fu, L Chen - Bioorganic Chemistry, 2023 - Elsevier
As an integral organelle in the eukaryote, the lysosome is the degradation center and
metabolic signal center in living cells, and partakes in significant physiological processes …

Recent advances in electrochemical biosensors for the detection of Aβ42, a biomarker for Alzheimer disease diagnosis

M Ding, S Ding, D Du, X Wang, X Hu, P Guan… - TrAC Trends in …, 2023 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with a long latency in
the" prodromal" stage, for which there are currently no effective treatments. It is generally …

Metal–Organic Frameworks‐Based Nanoplatforms for the Theranostic Applications of Neurological Diseases

H Niu, H Bu, J Zhao, Y Zhu - Small, 2023 - Wiley Online Library
Neurological diseases are the foremost cause of disability and the second leading cause of
death worldwide. Owing to the special microenvironment of neural tissues and biological …

A survey of deep learning for alzheimer's disease

Q Zhou, J Wang, X Yu, S Wang, Y Zhang - Machine Learning and …, 2023 - mdpi.com
Alzheimer's and related diseases are significant health issues of this era. The
interdisciplinary use of deep learning in this field has shown great promise and gathered …

Trilateral association of autophagy, mTOR and Alzheimer's disease: Potential pathway in the development for Alzheimer's disease therapy

A Subramanian, T Tamilanban, A Alsayari… - Frontiers in …, 2022 - frontiersin.org
The primary and considerable weakening event affecting elderly individuals is age-
dependent cognitive decline and dementia. Alzheimer's disease (AD) is the chief cause of …

Hederagenin improves Alzheimer's disease through PPARα/TFEB-mediated autophagy

Z Xie, J Zhao, L Wu, S Chu, Z Cui, Y Sun, H Wang… - Phytomedicine, 2023 - Elsevier
Background Autophagic flux is coordinated by a network of master regulatory genes, which
centered on transcription factor EB (TFEB). The disorders of autophagic flux are closely …